Contract research firm ACR Image Metrix today announced a partnership with iCad Inc. to conduct a multi-reader clinical study on the effectiveness of the CT Colon Computer-Aided Detection system.
Specifically, the two seek to determine whether the addition of the CAD system enables radiologists interpreting CT colonography images to detect more cancers than they would without utilizing the iCAD system in the image interpretation process. They will develop and execute a clinical study to support U.S. Food and Drug Administration (FDA) approval of CT Colon CAD.
“ACR Image Metrix is proud to undertake such an important study. CT colonography is a cutting edge technology that has the potential to save countless thousands of lives when effectively utilized,” said Bruce J. Hillman, M.D., FACR, ACR Image Metrix director of scientific affairs. “It is important to know whether adjunct technologies such as CAD can help make CT colonography even more effective at detecting colorectal cancer, the nation’s second leading cancer killer.”